obeticholic acid Ocaliva PBC
Selected indexed studies
- New Treatment Paradigms in Primary Biliary Cholangitis. (Clin Gastroenterol Hepatol, 2023) [PMID:36809835]
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (J Hepatol, 2017) [PMID:28427765]
- Primary biliary cholangitis: Epidemiology, prognosis, and treatment. (Hepatol Commun, 2023) [PMID:37267215]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Obeticholic acid-a new therapy in PBC and NASH. (2020) pubmed
- New Treatment Paradigms in Primary Biliary Cholangitis. (2023) pubmed
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) pubmed
- Primary biliary cholangitis: Epidemiology, prognosis, and treatment. (2023) pubmed
- Cholestatic liver diseases: modern therapeutics. (2025) pubmed
- COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls. (2025) pubmed
- Primary biliary cholangitis: Personalizing second-line therapies. (2025) pubmed
- Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Therapy Landscape. (2025) pubmed
- PMID:30525349 (2017) pubmed
- Second-Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta-Analysis. (2025) pubmed